Smart bombs for lung cancer: new ADC drugs enter trial
NCT ID NCT06780098
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 3 times
Summary
This phase 2 trial tests two antibody-drug conjugates (ADCs) — R-DXD and I-DXD — against standard chemotherapy in 144 people with advanced squamous non-small cell lung cancer that has worsened after initial treatment. ADCs are like guided missiles that deliver a cancer-killing drug directly to tumor cells. The study measures how many tumors shrink and how safe the treatments are.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Raludotatug deruxtecan and Ifinatamab deruxtecan (antibody-drug conjugates)
- What this could lead to
- If successful, these antibody-drug conjugates could offer a new treatment option for people with advanced squamous lung cancer that has stopped responding to standard therapies.
- What could go wrong
- This is a phase 2 trial with only 144 participants, so results are preliminary. The treatments may not work better than chemotherapy and could cause side effects like infusion reactions or organ damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Ankara Bilkent Şehir Hastanesi. ( Site 0142)
RECRUITINGAnkara, 06800, Turkey (Türkiye)
-
Azienda Ospedaliera Universitaria Careggi ( Site 0173)
RECRUITINGFlorence, 50134, Italy
-
Bacs-Kiskun Varmegyei Oktatokorhaz ( Site 0063)
RECRUITINGKecskemét, Bács-Kiskun county, 6000, Hungary
-
Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 0141)
RECRUITINGAdana, 01250, Turkey (Türkiye)
-
Beijing Cancer Hospital ( Site 0301)
RECRUITINGBeijing, Beijing Municipality, 100142, China
-
Bradfordhill ( Site 0162)
RECRUITINGSantiago, Region M. de Santiago, 8420383, Chile
-
Centro de Estudios Clínicos SAGA ( Site 0161)
RECRUITINGSantiago, Region M. de Santiago, 7500653, Chile
-
Charite-Universitaetsmedizin Berlin ( Site 0191)
RECRUITINGBerlin, 13353, Germany
-
Chongqing University Cancer Hospital ( Site 0304)
RECRUITINGChongqing, Chongqing Municipality, 400030, China
-
EVANGELISMOS S.A ( Site 0206)
RECRUITINGAthens, Attica, 106 76, Greece
-
Ege Universitesi Hastanesi ( Site 0143)
RECRUITINGIzmir, İzmir, 35100, Turkey (Türkiye)
-
European Interbalkan Medical Center-Oncology Department ( Site 0205)
RECRUITINGThessaloniki, 570 01, Greece
-
FALP ( Site 0160)
RECRUITINGSantiago, Region M. de Santiago, 7500921, Chile
-
Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 0175)
RECRUITINGMilan, 20133, Italy
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 0174)
RECRUITINGRoma, 00168, Italy
-
Fujian Provincial Cancer Hospital ( Site 0310)
RECRUITINGFuzhou, Fujian, 350014, China
-
Guangxi Medical University Cancer Hospital ( Site 0303)
RECRUITINGNanning, Guangxi, 530201, China
-
Hacettepe Universitesi Tip Fakultesi Hastanesi ( Site 0140)
RECRUITINGAnkara, 06230, Turkey (Türkiye)
-
Henan Cancer Hospital ( Site 0311)
RECRUITINGZhengzhou, Henan, 450000, China
-
Hospital Clinic de Barcelona ( Site 0092)
RECRUITINGBarcelona, 08008, Spain
-
Hospital Universitario Quiron Madrid ( Site 0091)
RECRUITINGMadrid, 28223, Spain
-
Institut Català d'Oncologia - L'Hospitalet ( Site 0090)
RECRUITINGL'Hospitalet de Llobregat, Barcelona, 08908, Spain
-
Istanbul Universitesi Cerrahpasa Tip Fakultesi ( Site 0144)
RECRUITINGIstanbul, 34098, Turkey (Türkiye)
-
Jasz-Nagykun-Szolnok Varmegyei Hetenyi Geza Korhaz-Rendelointezet ( Site 0061)
RECRUITINGSzolnok, Jász-Nagykun-Szolnok, 5000, Hungary
-
MedStar Franklin Square Medical Center ( Site 0033)
RECRUITINGBaltimore, Maryland, 21237, United States
-
Meir Medical Center ( Site 0071)
RECRUITINGKfar Saba, 4428164, Israel
-
Nanjing Drum Tower Hospital JiangBei International Branch Hospital ( Site 0309)
RECRUITINGNanjing, Jiangsu, 210031, China
-
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie ( Site 0151)
RECRUITINGWarsaw, Masovian Voivodeship, 02-781, Poland
-
Ospedale San Raffaele. ( Site 0171)
RECRUITINGMilan, 20132, Italy
-
Petz Aladar Egyetemi Oktato Korhaz ( Site 0062)
RECRUITINGGyőr, Győr-Moson-Sopron, 9024, Hungary
-
Rabin Medical Center ( Site 0074)
RECRUITINGPetah Tikva, 4941492, Israel
-
Rambam Health Care Campus ( Site 0076)
RECRUITINGHaifa, 3109601, Israel
-
Shaare Zedek Medical Center ( Site 0075)
RECRUITINGJerusalem, 9103102, Israel
-
Shanghai Chest Hospital ( Site 0308)
RECRUITINGShanghai, Shanghai Municipality, 200030, China
-
Shanghai Pulmonary Hospital ( Site 0300)
RECRUITINGShanghai, Shanghai Municipality, 200433, China
-
Sheba Medical Center ( Site 0070)
RECRUITINGRamat Gan, 5265601, Israel
-
Sourasky Medical Center ( Site 0077)
RECRUITINGTel Aviv, 6423906, Israel
-
Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie ( Site 0152)
RECRUITINGKoszalin, West Pomeranian Voivodeship, 75-581, Poland
-
THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA" ( Site 0204)
RECRUITINGAthens, Attica, 115 27, Greece
-
Texas Oncology - DFW ( Site 8003)
RECRUITINGDallas, Texas, 75246-2046, United States
-
UniversitaetsklInikum Tuebingen ( Site 0192)
RECRUITINGTübingen, Baden-Wurttemberg, 72076, Germany
-
University of Kentucky Chandler Medical Center ( Site 0019)
RECRUITINGLexington, Kentucky, 40536-0293, United States
-
Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150)
RECRUITINGGdansk, Pomeranian Voivodeship, 80-214, Poland
-
Wielkopolskie Centrum Pulmonologii i Torakochirurgii ( Site 0153)
RECRUITINGPoznan, Greater Poland Voivodeship, 60-569, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immune drug outsmart Hard-to-Treat tumors?
- One pill before radiation: a new shield for bones?
- Listening to patients: what symptoms follow lung ablation?
- Ultrasound could reveal hidden lung changes after surgery
- New hope for elderly lung cancer patients: combined surgery and rehab study launches
- Lung cancer mRNA vaccine trial pulled before it began